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ABSTRACT
We have previously reported that the CDX1 homeo-
protein interacts with the TATA-box binding
protein (TBP) on the promoter of the glucose-6-
phosphatase (G6Pase) gene. We show here that
CDX1 interacts with TBP via the homeodomain and
that the transcriptional activity additionally requires
the N-terminal domain upstream of the home-
odomain. CDX1 interacting with TBP is connected
to members of the TFIID and Mediator complexes,
two major elements of the general transcriptional
machinery. Transcription luciferase assays per-
formed using an altered-specificity mutant of TBP
provide evidence for the functionality of the inter-
action between CDX1 and TBP. Unlike CDX1, CDX2
does not interact with TBP nor does it transactivate
the G6Pase promoter. Swapping experiments bet-
ween the domains of CDX1 and CDX2 indicate that,
despite opposite functional effects of the homeo-
proteins on the G6Pase promoter, the N-terminal
domains and homeodomains of both CDX1 and
CDX2 have the intrinsic ability to activate transcrip-
tion and to interact with TBP. However, the carboxy
domains define the specificity of CDX1 and CDX2.
Thus, intra-molecular interactions control the activ-
ity and partner recruitment of CDX1 and CDX2,
leading to different molecular functions.
INTRODUCTION
Homeobox-containing genes encode a large family of
transcription factors involved in body plan organization
during embryogenesis and in tissue homeostasis in many
adult organs (1,2). Mutations within these genes cause
malformations and metabolic diseases. In addition, several
lines of evidence indicate that changes in homeobox gene
expression are involved in malignant tumor progression
(3,4). Although homeobox genes are thought to control
large genetic programs, their molecular mechanisms of action
are not fully elucidated.
The three mammalian homeobox genes of the CDX family,
related to the Drosophila gene caudal, are major components
of the network that deﬁnes the antero-posterior axis in
embryos. At the adult stage, CDX1 and CDX2 remain
selectively active in the continuously renewing intestinal
epithelium (5,6). Although CDX2 is expressed in most gut
epithelial cells, CDX1 expression is limited to crypts cells,
which belong to the proliferating cell compartment (7). The
two genes have both common and speciﬁc cellular effects.
Indeed, whereas they both trigger cell differentiation, CDX1
stimulates while CDX2 decreases proliferation in cell
cultures (8–10). They are also differently targeted by regula-
tory pathways as for example, CDX1 is directly upregulated
by Wnt/b-catenin signaling (11), which is mostly active in the
crypt compartment, whereas CDX2 is indirectly downregu-
lated by this pathway (12). Transgenic models have provided
further evidence that the CDX1 and CDX2 genes exert both
common and speciﬁc effects in relation to pathological
conditions. Indeed, on the one hand the ectopic expression
of either CDX1 or CDX2 causes intestinal-type metaplasia
of the gastric epithelium (13). On the other hand, CDX2
has been shown to play a tumor suppressor role in murine
models of sporadic and genetic colorectal cancers (14,15),
whereas CDX1 was reported to mediate the hyperprolifera-
tive condition linked to Rb and p130 deﬁciency in the gut
(16). Outside the gut, recent studies have reported that the
CDX2 and CDX1 proteins have different effects on the
promoters of genes involved in early embryonic development
(17). On this basis, it is therefore important to delineate the
speciﬁc molecular functions of the CDX1 and CDX2
proteins.
One mechanism to account for the different effects exerted
by the CDX1 and CDX2 proteins postulates that they could
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CDX2 proteins exhibit extensive sequence similarity in
their homeodomains responsible for DNA-binding (96.6%),
whereas the percentage of identity is lower in the N-terminal
(35.5%) and C-terminal domains (36.5%) ﬂanking the home-
odomain. We have recently shown that the promoter of the
glucose-6-phosphatase (G6Pase) gene is selectively activated
by CDX1, whereas CDX2 counteracts this stimulatory effect
(18). Both homeoproteins bind to the G6Pase promoter at the
level of the TATA-box, but only CDX1 was found to interact
with the TATA-box binding protein (TBP) by means of
co-immunoprecipitation. In the present study, we have
analyzed the functionality of the interaction between TBP
and CDX1, and we have used hybrid molecules between
CDX1 and CDX2 to investigate the differential effects of
these homeoproteins on the G6Pase promoter.
MATERIALS AND METHODS
Plasmids
The plasmids encoding CDX1, CDX2, HA-CDX1, HA-
CDX2, CDX1-HD2, CDX2-HD1, TBP, HA-TBP and TBP-
spm3 were described previously (8,18,19). To simplify the
nomenclature, CDX1-HD2 and CDX2-HD1 were renamed
into ND1-HD2-CD1 and ND2-HD1-CD2, respectively,
where ND represents the N-terminal domain, HD the home-
odomain, and CD the C-terminal domain of these homeopro-
teins. Hybrid forms with glutathione S-transferase (GST)
fused upstream of CDX1 or CDX2 were constructed in the
pBC vector (20). For this purpose, the plasmids pCB6-
CDX1S and pCB6-CDX2S modiﬁed with a NheI site inserted
immediately downstream of the translation start-site (18)
were cut with NheI, ﬁlled in with T4 DNA polymerase and
cut with BamHI. The resulting fragments were introduced
into the EcoRV/BamHI sites of pBC. Plasmids encoding trun-
cated forms of HA-CDX1 were constructed as follows (see
also Figure 3). The plasmid coding for the mutant HA-
ND1-HD1, deleted of the C-terminal domain downstream
of the homeodomain, was obtained by introducing a stop
codon in pCB6-HA-CDX1 (18) using the Gene Editor 
in vitro site directed mutagenesis system (Promega) and the
oligonucleotide 50-AAAGTAAACAAGAAGAGCTAGCAG-
CAGCAGCAGCCC-30. The plasmid encoding HA-ND1
corresponding to the N-terminal domain and deleted of the
homeodomain and the C-terminal domain was constructed
by PCR using the primers 50-CACCATGCTAGCATATCC-
CTATGACGTCCCAGACTA-30/50-ACCGGTTGTGTAGA-
CCACACGTGACTTGTC-30 and pCB6-HA-CDX1 as tem-
plate; the resulting PCR fragment was cloned into the vector
pcDNA3.1/V5-His by TOPO-TA cloning (Invitrogen). The
plasmid encoding the mutant form having the homeodomain
linked to the C-terminal domain, HA-HD1-CD1, was con-
structed similarly from pCDX2-S using the PCR primers 50-
CACCATGCTAGCATATCCCTATGACGTCCCAGACTA-
TGCGCTAGCTCGGCGCAGCGTGGCGGCTGCAGGC-30/
50-ACCGGTGGGTAGAAACTCCTCCTTGACGGG-30.H i g h
ﬁdelity Platinum Taq DNA polymerase (Invitrogen) was used
for PCR. To construct plasmids encoding the proteins HA-
ND1-HD2-CD2 and HA-ND2-HD1-CD1, we ﬁrst changed
the GTGGTCTACACAGAC sequence of pCB6-HA-CDX1
into GTGGTGTACACAGAC to create a Bsrg1 restriction
site upstream of the homeobox without changing the encoded
protein sequence. Then, the resulting plasmid and the plasmid
pCB6-HA-CDX2 were cut with NheI and Bsrg1, and the cor-
responding Nhe1/Bsrg1 restriction fragments were swapped
between both plasmids. The reporter luciferase plasmids
pG6Pase-Luc containing the  36 to +60 nt of the G6Pase
promoter (18) and pTGTA-Luc (19) were described previ-
ously. The plasmid pTGTA-G6Pase-Luc was constructed by
changing the TATA-box of pG6Pase-Luc into TGTAAAA
using the oligonucleotide 50-ACAGACTGAATCCAGGGC-
ATGTAAAATGGGCAAGGCACAGA-30 and the Gene
Editor  in vitro site directed mutagenesis system (Promega).
All plasmids were conﬁrmed by sequencing.
Cell transfections, protein extractions, in vitro
translation and luciferase assays
HCT116 and HepG2 cells were cultured in DMEM with
10 and 20% FBS, respectively, at 37 C in humidiﬁed atmo-
sphere under 5% CO2. Cells at 70–80% conﬂuence were
co-transfected using JET-PEI (Polyplus Transfection) with
the indicated plasmids and either pEGFP-C1 (Clontech) or
the Renilla luciferase control vector pRL-null (Promega) to
monitor transfection efﬁciency. For biochemical analyses,
cells were scraped 48 h after transfection in ice-cold NP-40
lysis buffer (20 mM Tris at pH 7.5, 150 mM NaCl, 1%
Igepal) and a cocktail of protease inhibitors (Sigma), put 10
min on ice and centrifuged in an Eppendorf 5417R, Rotor
F45-30-11 at 10 000 g for 10 min at 4 C. The supernatant
was removed and assayed for protein concentration using
Bradford reaction. For luciferase assays, cells were lysed in
Passive Lysis Buffer (Promega), and ﬁreﬂy luciferase and
Renilla luciferase activities were measured sequentially
using the dual-luciferase assay reporter system (Promega).
Fireﬂy luciferase activity was normalized with Renilla
luciferase activity and the data were expressed as fold of induc-
tion in the experimental condition compared to the control.
For in vitro production of the full-length HA-CDX1 protein
or the truncated form HA-HD1, PCR fragments were respec-
tively produced using pCB6-HA-CDX1 and pCB6-HA-HD1-
CD1 as templates and the forward primer containing the T7
promoter 50-GGATCCTAATACGACTCACTATAGGGAA-
CAGCCACCATGCTAGGATATCCCTATGACGTC-30 together
with the speciﬁc reverse primers 50-30x(T)AGGGTA-
GAAACTCCTCCTT GACCGGGCACTG-30 or 50-30x(T)AT-
ACTTTGCGCTCCTTGGCCCGGCGGTTCT-30, respectively.
In vitro transcription/translation were performed by adding
500 ng of PCR fragment to the synthesis mixture (TNT-T7
Quick coupled Transcription/Translation System, Promega)
containing 40 mCi of [
35S]Methionine (1000 Ci/mmol and
10 mCi/mL, Amersham), as recommended by the supplier.
GST-pulldown and co-immunoprecipitation assays
GST-pulldown was performed using glutathione–Sepharose-
4B beads (Amersham Biosciences), on either protein extracts
of cells transfected with the plasmids encoding GST, GST-
CDX1 or GST-CDX2, or on protein extracts of bacteria trans-
formed with the plasmid pGST-TBP (21). After 3 h incuba-
tion under gentle agitation at 4 C, the beads were washed
in lysis buffer and proteins were analyzed by SDS–PAGE.
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HA-tagged CDX1, CDX2, TBP or TBP-spm3 were subjected
to immunoprecipitation using anti-HA antibody matrix
(3F10, Roche). Alternatively, immunoprecipitation was
performed using rabbit anti-CDX1 [C1C, (15)], mouse anti-
CDX2 (392 M, Biogenex) or mouse anti-TBP [3G3, (22)]
antibodies and subsequent incubation overnight at 4 C with
protein A-agarose or protein G-agarose beads (Roche).
Then, the beads were washed in lysis buffer and the proteins
were analyzed by SDS–PAGE and western blot, as described
(23). Brieﬂy, they were transferred on to nitrocellulose ﬁlters
and identiﬁed using the primary antibodies raised against
GST (G7781 Sigma, dilution 1:5000), HA (3F10, Roche,
dilution 1:1000), CDX1 [C1C (15), dilution 1:2000], CDX2
(392M, Biogenex, dilution 1:5000), MED7 (dilution 1:10,
kindly provided by Dr M. Meisterernst), TBP (3G3,
dilution 1:2000), TAF7 (19TA, dilution 1:1000), TAF15
(16TA, dilution 1:1000) and TAF12 [22TA, dilution
1:1000 (22)]. Immunodetection used sheep anti-mouse k-
chain immunoglobulins (dilution 1:5000) or donkey anti-
rabbit immunoglobulins (dilution 1:5000) or sheep anti-rat
immunoglobulins (dilution 1:5000) coupled to horseradish
peroxydase (HRP) (Amersham Biosciences). The ﬁlters
were developed using ECL chemiluminescence (Amersham
Biosciences).
Immunocytofluorescence
Cells cultured in eight chamber slides (Lab-Tek) were taken
24 h after transfection, ﬁxed in 4% paraformaldehyde for
10 min and incubated 1 h in phosphate-buffered saline
(PBS) containing 0.3% Triton X-100 and 5% normal goat
serum. Primary polyclonal anti-HA antibody (Sigma
H6908, dilution 1:1000) was added for overnight incubation
at 4 C and the primary antibody was detected by ﬂuorescence
using goat anti-rabbit immunoglobulins coupled to Alexa
488 (Molecular Probes, dilution 1:1000) for 1 h in the dark.
Cell nuclei were stained with DAPI and slides were mounted
in Glycerol/PBS/Phenylenediamine for observation using an
Olympus AX60 microscope.
RESULTS
Selective interaction of TBP with the homeoprotein
CDX1 but not with CDX2
We have used two methods to examine the selective interac-
tion of CDX1 with TBP. When introduced by co-transfection
into HCT116 cells, overexpressed TBP was co-
immunoprecipitated by HA-tagged CDX1, but not by HA-
CDX2 (Figure 1A). To provide evidence that the interaction
between TBP and HA-CDX1 is unrelated to the HA-tag and
to demonstrate the interaction with a method not dependent
on antibodies, we used plasmids encoding GST-fusion
versions of CDX1 and CDX2 to perform GST-pulldown
assays. After co-transfection with the corresponding
plasmids, the results conﬁrmed the selective interaction of
TBP with CDX1, and the absence of interaction with
CDX2 (Figure 1B). We then investigated if endogenous
TBP can be trapped by GST-CDX1 or HA-CDX1. For this
purpose, HCT116 or HepG2 cells were transfected only
with the plasmids encoding the GST-fusion or HA-tagged
forms of CDX1. HA co-immunoprecipitation (Figure 1C) or
GST-pulldown (data not shown) indicated that endogenous
TBP was recovered together with CDX1. In contrast, no
TBP was retained in similar experiments conducted with
HA-tagged or GST-fusion forms of CDX2, demonstrating
the selectivity of the interaction between CDX1 and endoge-
nous TBP (Figure 1C). Since CDX2 does not interact with
TBP, we checked the possibility of an interaction with the
TBP-related protein TLF/TRF2. Like for TBP, no interaction
was detected between CDX2 and TLF/TRF2. In addition, we
also failed to detect any interaction between CDX1 and TLF/
TRF2, which strengthens the speciﬁcity of the CDX1/TBP
interaction (data not shown).
Characterization of the CDX1–TBP interaction
To further address the nature of the interaction between
CDX1 and TBP, GST-TBP was produced in bacteria and
HA-CDX1 in transfected HCT116 cells. After binding of
GST-TBP by afﬁnity to glutathione–Sepharose-4B beads,
the beads coupled to GST-TBP were mixed with the extracts
of HA-CDX1 transfected cells. Subsequently, GST-pulldown
and western blot analysis with anti-HA antibody
demonstrated that CDX1–TBP interaction occurred in vitro
(Figure 2A). Then we synthesized HA-CDX1 by in vitro
transcription/translation and the resulting translation product
was mixed with the glutathione–Sepharose-4B beads coupled
to GST-TBP. In this condition, no interaction between CDX1
and TBP was observed (Figure 2B).
The lack of interaction between TBP and in vitro translated
CDX1, in contrast to HCT116 cells-produced CDX1, could
result from an inappropriate folding of the protein when
translated in vitro. Alternatively, the TBP–CDX1 interaction
could depend on additional factors missing in the in vitro
translation system. Since TBP associates with many factors,
the TAFs (TBP-associated factors), within the TFIID
multiprotein complex (24), we checked whether additional
members of TFIID can be co-immunoprecipitated with HA-
CDX1. As control, HCT116 cells transfected with HA-TBP
were used to demonstrate that endogenous TAFs, namely
TAF7 (55 kDa), TAF15 (15 kDa) and TAF12 (20 kDa),
actually co-immunoprecipitated with HA-tagged TBP in our
conditions (Figure 2C). Then we conducted a similar experi-
ment with HA-CDX1 transfected cells. As shown in
Figure 2C, TAF7, TAF15 and TAF12 were also recovered
by co-immunoprecipitation with HA-CDX1, although less
efﬁciently than with HA-TBP. In addition to TFIID, recruit-
ment and/or binding of TBP onto the TATA-box is facilitated
by the Mediator complex (25). Several Mediator complexes
have been described in mammalian cells, all containing the
Med7 factor (also called Med34). As expected, endogenous
Med7 was co-immunoprecipitated using anti-HA antibody
in HA-TBP transfected HCT116 cells; strikingly, Med7 was
also co-immunoprecipitated with HA-CDX1 in HA-CDX1
transfected cells (Figure 2C). Together, these data indicate
that CDX1 is tightly associated with the TFIID multiprotein
complex including TBP, as well as with the Mediator
complex.
We have previously shown by electrophoretic mobility
shift assay (EMSA) that CDX1 and TBP bind together on
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To address the importance of DNA in the CDX1–TBP
interaction, HA-immunoprecipitation experiments were per-
formed in the presence of increasing amount of the DNA
intercalary agent, ethidium bromide. In cells co-transfected
with HA-CDX1, the interaction with endogenous TBP was
not altered by ethidium bromide at 10 mg/ml, a concentration
that has been shown to strongly inhibits the interaction
between the transcription factor Oct1 and its partners (26).
However, at the higher dose of 50 mg/ml the CDX1–TBP
interaction was prevented, suggesting that, although not
required, the DNA may facilitate the interaction. Yet, the
addition of DNA containing the G6Pase TATA-box was
unable to restore this interaction in the experiments in
which bacterially-produced GST-TBP was mixed to in vitro
translated HA-CDX1 (data not shown).
Collectively, these results indicate that CDX1 interacts
with two major multiprotein complexes of the transcriptional
machinery, the TBP-containing TFIID complex and the
Med complex, and that the interaction is facilitated by
DNA, indicating that CDX1, TBP and DNA form a ternary
complex. However, these experiments do not formally dem-
onstrate the direct physical interaction between CDX1 and
TBP. In the following, protein interaction between CDX1
and TBP will be used by means of co-immunoprecipitation
or GST-pulldown experiments.
Requirement of different domains of CDX1 for TBP-
binding and transactivation
To map the domain of CDX1 responsible for interacting with
TBP, we constructed a series of truncated mutants of this
homeoprotein, all having the nuclear localization signal of
CDX1 and the HA epitope (Figure 3A). The N-terminal
domain upstream of the homeodomain and the C-terminal
domain downstream of the homeodomain were deleted in
the mutants HA-HD1-CD1 and HA-ND1-HD1, respectively.
The homeodomain and the C-terminal domain were deleted
in the mutant HA-ND1, leaving only the N-terminal domain
linked to the nuclear localization signal. Immunoﬂuorescence
staining with anti-HA antibody in transfected HCT116
(Figure 3B) and in HepG2 cells (data not shown) revealed
Figure 1. Interaction of TBP with CDX1 but not with CDX2. (A) Specific co-immunoprecipitation of TBP and HA-CDX1. HCT116 cells were co-transfected
with the plasmids encoding TBP and either HA-CDX1, HA-CDX2 or the control empty vector, as indicated. Proteins immunoprecipitated with anti-HA antibody
were detected by western blots using anti-HA to control the immunoprecipitation step and anti-TBP antibody to detect the co-immunoprecipitation of TBP. TBP
was recovered in the fraction immunoprecipitated with HA-CDX1 but not with HA-CDX2. The presence of TBP in the cell extracts prior to HA-
immunoprecipitation was controlled by western blot using anti-TBP antibody (Input). (B) Specific GST-pulldown of overexpressed TBP with GST-CDX1.
HCT116 cells were co-transfected with the plasmids encoding TBP and either GST-CDX1, GST-CDX2 or the control GST vector, pBC. GST-pulldown extracts
were analyzed by western blots using anti-GST antibody and assayed for the presence of TBP using anti-TBP antibody. TBP was recovered in the fraction
containing GST-CDX1 but not GST-CDX2. The presence of TBP in the cell extracts prior to GST-pulldown was controlled by western blot using anti-TBP
antibody (Input). The lower panel demonstrates overexpression of TBP in total extracts of HCT116 cells transfected with the TBP-encoding plasmid as compared
to cells transfected with the empty vector. (C) Specific co-immunoprecipitation of endogenous TBP by HA-CDX1. HepG2 cells were transfected with the
plasmids encoding HA-CDX1, HA-CDX2 or the control plasmid. Immunoprecipitation was performed as described in A with anti-HA antibody followed by
western blot analysis with anti-HA or anti-TBP. HA-CDX1, but not HA-CDX2, was able to interact with endogenous TBP. The presence of TBP in the cell
extracts prior to HA-immunoprecipitation was controlled by western blot using anti-TBP antibody (Input).
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sively in the nucleus, like the full-length HA-CDX1. The
truncated protein HA-ND1 containing the N-terminal domain
linked to the nuclear localization sequence was also present
in the nucleus, but a diffuse ﬂuorescence labeling was also
detected in the cytoplasm, indicative of less efﬁcient import
or retention in the nucleus.
The different HA-tagged CDX1 mutants were then
checked for their ability to co-immunoprecipitate endogenous
TBP, using anti-HA antibody. Figure 3C shows that the
HA-ND1-HD1 and HA-HD1-CD1 mutants, which have the
nuclear localization signal and the homeodomain in common,
were both able to interact with TBP as efﬁciently as wild-type
CDX1. However HA-ND1, lacking both the homeodomain
and the C-terminal domain, no longer interacted with TBP.
Taken together, these data strongly suggest that the
homeodomain is crucial for the interaction between CDX1
and TBP. We have also created an expression plasmid encod-
ing the truncated form containing only the nuclear localiza-
tion signal plus the homeodomain of CDX1, but we failed
to detect this protein after transfection, suggesting that it is
likely degraded. When synthesized in vitro by in vitro
transcription/translation, the polypeptide overlapping only
the homeodomain of CDX1, HD1, was not able to interact
with GST-TBP (data not shown), as observed above for the
full-length CDX1 protein synthesized in vitro.
Next, we analyzed the transcriptional activity of the
different truncated mutants on the G6Pase promoter
Figure 2. Characterization of the CDX1/TBP interaction. (A) Interaction of bacterially-produced GST-TBP and cellular HA-CDX1. GST or GST-TBP produced
in bacteria was bound to glutathione–Sepharose-4B beads [see also the first two lanes in (B)] and mixed with HCT116 cells extracts containing HA-CDX1. After
GST-pulldown, the presence of GST and GST-TBP was revealed using anti-GST antibody, and the presence of HA-CDX1 was detected using anti-HA antibody.
The presence of HA-CDX1 in the cell extracts prior to GST-pulldown was control by western blot with anti-HA antibody (Input). (B) Lack of interaction between
bacterially-produced GST-TBP and in vitro translated HA-CDX1. GST (first lane, Coomasie blue staining) and GST-TBP (second lane, Coomasie blue staining)
were produced in bacteria and bound to glutathione–Sepharose-4B beads.
35S-Methionine-labeled HA-CDX1 was synthesized by in vitro transcription/translation
(third lane, autoradiography). By mixing GST and HA-CDX1 (fourth lane) or GST-TBP and HA-CDX1 (fifth lane), no interaction was detected after GST-
pulldown and autoradiography. (C) CDX1 interaction with components of the TFIID and Med complexes. HCT116 cells were transfected with the control empty
vector or with the plasmids encoding HA-TBP or HA-CDX1. Proteins immunoprecipitated with anti-HA antibody were detected by western blots using the
antibodies raised against TAF7, TAF12, TAF15 and Med7. D. Effect of ethidium bromide (EtBr) on the CDX1/TBP interaction. HCT116 were transfected with
the plasmid encoding HA-CDX1 and the proteins were immunoprecipitated with anti-HA antibody in the presence of increasing amount of ethidium bromide.
Western blot with anti-HA antibody was used to control the step of immunoprecipitation and anti-TBP was used to detect the co-immunoprecipitated TBP. The
presence of TBP in every cell extract prior to co-immunoprecipitation was controlled using anti-TBP antibody (Input).
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with the reporter plasmid pG6Pase-Luc led to a nearly
30-fold stimulation of transcriptional activity. A 30-fold
stimulation was also obtained with the HA-ND1-HD1
mutant, lacking the C-terminal domain of CDX1. However,
it is worth noting that the HA-HD1-CD1 mutant was devoid
of transcriptional activity, despite its ability to interact with
TBP. The mutant HA-ND1 that did not interact with
TBP was also transcriptionally inactive. These data indicate
that the TBP-binding and transactivation activities map
on discrete domains of CDX1, respectively the homeo-
domain and the N-terminal domain, and that cooperation
between both domains is required for efﬁcient function of
CDX1.
Dependence of the TBP-binding activity of the
CDX1 and CDX2 homeodomains to regions outside
the homeodomains
Although CDX2, unlike CDX1, does not interact with TBP,
we asked if the CDX2 homeodomain could be turned on to
bind TBP in the context of CDX1. Reciprocally, we investi-
gated the TBP-binding activity of the CDX1 homeodomain in
the context of CDX2. The homeodomains of CDX1 and
CDX2 differ signiﬁcantly at 2 amino acid, the residues
N190 and T194 of CDX1 corresponding to T221 and S225
in CDX2 (18). Changing N190 and T194 of CDX1, respec-
tively into T and S creates the chimeric molecule
ND1-HD2-CD1 in which the homeodomain of CDX2 is
placed in the context of CDX1 whereas, replacing T221
Figure 3. Requirement of different domains of CDX1 for TBP-binding and transactivation. (A) Schematic representation of the truncated forms of CDX1. HA:
hemagglutinin epitope, NLS: nuclear localization signal, HD: homeodomain. (B) Intracellular distribution of the recombinant proteins. HCT116 cells were
transfected with the plasmids encoding the indicated proteins and immunolabeled with primary rabbit anti-HA antibody followed by secondary anti-rabbit
immunoglobulins coupled to Alexa 488. Cell nuclei were stained with DAPI. Arrows denote cells expressing the mutant forms of CDX1; arrowheads indicate
nuclei of non-transfected cells labeled only with DAPI. (C) Co-immunoprecipitation of TBP with the truncated forms of CDX1. HCT116 cells were co-
transfected with the plasmids encoding TBP and either HA-CDX1, HA-ND1-HD1, HA-ND1, HA-HD1-CD1 or the control empty vector. Proteins
immunoprecipitated with anti-HA antibody were detected by western blots using anti-HA and co-immunoprecipitation of TBP was assayed using anti-TBP. TBP
was recovered in every fraction except with HA-ND1. The presence of TBP in the cell extracts prior to HA-immunoprecipitation was controlled by western blot
using anti-TBP antibody (Input). (D) Transcriptional activity of the truncated forms of CDX1. HepG2 cells were co-transfected with the reporter plasmid
pG6Pase-Luc and with each of the expression vectors encoding HA-CDX1, HA-ND1-HD1, HA-ND1 or HA-HD1-CD1, together with the control reporter pRL-
null. The data obtained in triplicate ±SD are representative of three independent experiments.
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cule ND2-HD1-CD2 in which the homeodomain of CDX1
is placed in the context of CDX2. Luciferase assays using
the G6Pase promoter indicated that ND1-HD2-CD1
stimulated the transcriptional activity like CDX1, whereas
ND2-HD1-CD2 was much less active than CDX1, like
CDX2 [Figure 4A, (18)].
Next, we performed co-immunoprecipitation assays to
investigate the interaction of the chimeric proteins with TBP.
Figure 4B shows that ND1-HD2-CD1 immunoprecipitated
Figure 4. Interaction of TBP with chimeric mutants of CDX1 and CDX2. (A). Transcriptional activity of the swapped mutants of CDX1 and CDX2 at the level of
the homeodomain. HepG2 cells were co-transfected with the reporter plasmids pG6Pase-Luc and pRL-null and with the expression plasmids encoding CDX1o r
CDX2 or ND1-HD2-CD1 or ND2-HD1-CD2. Relative transactivation levels, obtained from the measurements of luciferase activity, are given ±SD for four
independent experiments in triplicate. (B) Cells were transfected with the plasmids encoding CDX1 or ND1-HD2-CD1, or with the plasmids encoding CDX2 or
ND2-HD1-CD2. The proteins immunoprecipitated, respectively, with anti-CDX1 or with anti-CDX2 were analyzed by western blot using anti-CDX1 and anti-
TBP antibodies, or with anti-CDX2 and anti-TBP antibodies. The presence of TBP in the cell extracts prior to immunoprecipitation was controlled by western
blot using anti-TBP antibody (Input). (C) Transcriptional activity of the swapped mutants of CDX1 and CDX2 at the level of the N-terminal domain. HepG2 cells
were co-transfected with the reporter plasmids pG6Pase-Luc and pRL-null and with the expression plasmids encoding HA-CDX1 or HA-CDX2 or ND2-HD1-
CD1 or ND1-HD2-CD2. Relative transactivation levels, obtained from the measurements of luciferase activity, are given ±SD for four independent experiments
in triplicate. (D) Cells were transfected with the plasmids encoding HA-CDX1, HA-CDX2, HA-ND1-HD2-CD2 or ND2-HD1-CD1. Proteins
immunoprecipitated with anti-HA antibody were analyzed by western blot using anti-HA and anti-TBP antibodies. The presence of TBP in the cell extracts
prior to immunoprecipitation was controlled by western blot using anti-TBP antibody (Input).
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nous TBP, like wild-type CDX1, whereas ND2-HD1-CD2
immunoprecipitated with anti-CDX2 was unable to interact
with TBP, like CDX2. Reciprocally, when TBP was immuno-
precipitated with anti-TBP antibody, ND1-HD2-CD1 was
recovered into the TBP fraction, like CDX1, whereas
CDX2 and the chimeric protein ND2-HD1-CD2 were not
recovered (data not shown). Therefore, these results indicate
ﬁrst, that both the CDX1 and the CDX2 homeodomains are
able to interact with TBP and second, that the actual binding
activity depends on the regions outside the homeodomains,
in the sense that the CDX1 context is permissive or
stimulatory for TBP-binding whereas the CDX2 context
exerts a dominant-negative effect on the homeodomain for
its binding to TBP.
Having demonstrated ﬁrst, that the homeodomain and
N-terminal domain of CDX1 are required for TBP interaction
and transcriptional activity, respectively (Figure 3), and
second that the regions of CDX2 outside the homeodomain
can blunt the CDX1 homeodomain for interaction with TBP
(Figure 4A and B), we constructed the chimeric protein in
which the N-terminal domain of CDX1 was linked to the
homeodomain and carboxy domain of CDX2 (HA-ND1-
HD2-CD2) as well as the reciprocal chimeric protein in
which the N-terminal domain of CDX2 was linked to
the homeodomain and carboxy domain of CDX1 (HA-ND2-
HD1-CD1). After transfection of the corresponding plas-
mids in HCT116 cells and co-immunoprecipitation with
anti-HA antibody, endogenous TBP was recovered with
both HA-ND1-HD2-CD2 and HA-ND2-HD1-CD1 proteins
(Figure 4D). However Luciferase assays with the G6Pase-
Luc reporter indicated that the HA-ND2-HD1-CD1
protein was transcriptionaly active, although less than
CDX1, whereas HA-ND1-HD2-CD2 was inactive, like
CDX2 (Figure 4C). This indicates that the N-terminal domain
of CDX2 confers transcriptional activity when linked to the
CDX1 homeodomain and C-terminal domain, and that the
carboxy domain of CDX2 is able to blunt the transcriptional
activity of the CDX1 N-terminal domain, yet without
compromising TBP interaction with the homeodomain.
Functional interaction and promoter selectivity of the
cooperation between CDX1 and TBP
While CDX1 stimulates the G6Pase promoter and interacts
with TBP associated with the TFIID complex, the functional-
ity of the interaction between CDX1 and TBP remains to be
established. To address this point, we investigated the ability
of CDX1 to cooperatively activate a reporter plasmid along
with TBP. Co-transfection experiments with TBP and
CDX1 to check their co-operativity on the pG6Pase-Luc
reporter plasmid gave uninterpretable results because of the
presence of the endogenous TBP. To circumvent this
problem, we used a previously-described model in which
the altered-speciﬁcity mutant of TBP, spm3, activates tran-
scription via a TGTA rather than via the canonical TATA
DNA-binding site (19,27). The reporter plasmid pTGTA-
Luc was co-transfected with the expression plasmids encod-
ing TBP-spm3 and/or HA-CDX1 (Figure 5A). As expected,
luciferase activity was stimulated by 8-fold in the presence
of TBP-spm3, whereas wild-type TBP was almost inactive
on this promoter. HA-CDX1 alone had no effect on this
promoter. Moreover, HA-CDX1 did not stimulate the tran-
scriptional effect of TBP-spm3 on the standard pTGTA-Luc
reporter plasmid. In parallel experiments, the GST-pulldown
recovery of HA-TBP-spm3 together with GST-CDX1 ruled
out the possibility that the failure of CDX1 to enhance the
stimulatory effect of TBP-spm3 on pTGTA-Luc was due to
a loss of interaction between CDX1 and TBP-spm3
(Figure 5B). We therefore created a variant of the G6Pase
promoter, pTGTA-G6Pase-Luc, in which the TATAAAA
sequence was changed into TGTAAAA. As shown in
Figure 5. Functional interaction between TBP and CDX1. (A) Lack of activity of CDX1 on the pTGTA-Luc reporter. HepG2 cells were co-transfected with the
reporter plasmids pTGTA-Luc and pRL-null, and with the expression plasmids encoding TBP-spm3, HA-CDX1, TBP or with the combination of TBP-spm3 plus
CDX1. The data obtained in triplicate ±SD are representative of three independent experiments. (B) Interaction of TBP-spm3 with CDX1. Cells were co-
transfected with the plasmid encoding HA-TBP-spm3 and the control vector pBC or the plasmid coding for GST-CDX1. GST-pulldown extracts were analyzed
by western blots using anti-GST and anti-HA antibodies, demonstrating the interaction between TBP-spm3 and CDX1. The presence of HA-TBP-spm3 in the cell
extracts prior to immunoprecipitation was controlled by western blot using anti-HA antibody (Input). (C) Synergistic effect of TBP-spm3 and CDX1 on the
pTGTA-G6Pase-Luc reporter plasmid. HepG2 cells were co-transfected with the reporter plasmids pTGTA-G6Pase-Luc and pRL-null, and with the expression
plasmids encoding HA-TBP-spm3, HA-CDX1 or HA-TBP-spm3 plus HA-CDX1. The data obtained in triplicate ±SD are representative of three independent
experiments.
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reporter was increased 15-fold in the presence of TBP-spm3,
whereas CDX1 alone had only a weak effect (4-fold). How-
ever important, when TBP-spm3 was coexpressed with
CDX1, a much stronger 35-fold stimulation of the pTGTA-
G6Pase was observed. This result demonstrates the function-
ality of the interaction between TBP-spm3 and CDX1,
speciﬁcally in the context of the TGTA-G6Pase promoter.
DISCUSSION
The TBP binds to TAFs within TFIID and also to Mediator,
two major complexes of the general transcription machinery,
whereas homeodomain proteins are transcription activators
acting in a stage- and/or tissue-speciﬁc manner. Here we
show by means of co-immunoprecipitation and GST-
pulldown that CDX1 interacts with TBP in connection to
several components of TFIID, TAF7, TAF12 and TAF15,
and to Med7, a common component of the Mediator
complexes. Unlike CDX1, CDX2 does not interact with
TBP. Truncated forms of CDX1 and swapped mutants
between CDX1 and CDX2 (Table 1) provide evidence that
separate domains of these homeoproteins, namely the N-
terminal domain, the central homeodomain and the
C-terminal domain, are involved in transcriptional activity,
TBP interaction and regulation, and that the combination of
these domains within CDX1 and CDX2 dictates their speciﬁc
function on the G6Pase promoter. Finally, using an altered-
speciﬁcity mutant of TBP, we demonstrate that the TBP–
CDX1 interaction is functional and that co-operativity is
selective for G6Pase promoter activation.
Co-immunoprecipitation and GST-pulldown indicate that
CDX1 and TBP belong to a common complex with TAFs,
although the direct physical interaction between CDX1 and
TBP could not be established. Indeed, while GST-TBP
interacts with CDX1 produced in intestinal cells, it does not
with in vitro translated CDX1 nor with the in vitro translated
homeodomain, which indicates either that the TBP–CDX1
interaction is indirect and needs cofactors, or that it is
direct but that the conformation of in vitro-synthesized
CDX1 or homeodomain is not adequate. However, evidence
is provided here for the functionality of the TBP–CDX1
interaction, using the speciﬁcity mutant of TBP, spm3 and
the TGTA variant of the G6Pase TATA-box. The use of
TBP-spm3 together with the TGTA variant of the G6Pase
promoter allowed us to bypass the effects of endogenous
TBP in cotransfections studies. Interestingly, we found that
CDX1 and TBP-spm3 cooperatively activate the pTGTA-
G6Pase-Luc reporter, but not the standard pTGTA-Luc vector
based on the RARAb2 proximal promoter, suggesting that
CDX1 functions in a context-dependent manner and that
sequences outside the TATA-box are also important for
controlling CDX1 DNA-binding and/or activity. Recently, it
has been shown that the base pair located 3 nt away from the
CDX binding site is involved in the mechanism by which
CDX2 discriminates among promoters of the UDP-
glucuronosyltransferase gene family for DNA-binding and
transcriptional activation (28). Introducing the corresponding
nucleotide changes within the pTGTA-Luc and pTGTA-
G6Pase-Luc plasmids did not modify the response of these
promoters to CDX1 (data not shown), which suggests that
other cis-elements, still to be elucidated, dictate the differen-
tial effects of CDX1 on the pTGTA-G6Pase and pTGTA-Luc
reporters.
Although CDX1 and CDX2 have a similar enhancer activ-
ity on several intestinal promoters, CDX1 but not CDX2
activates the G6Pase promoter and, moreover, CDX2 blunts
the stimulatory effect exerted by CDX1 on the G6Pase pro-
moter (18). CDX1 and CDX2 do not co-immunoprecipitate,
ruling out the possibility that CDX2 counteracts CDX1 by
trapping it into an inactive heterodimer (data not shown).
However, CDX2, like CDX1, is able to bind to the G6Pase
TATA-box (18), suggesting that the opposite transcriptional
effects of both proteins result from their intrinsic properties.
Three domains are generally reported in homeoproteins, with
the DNA-binding homeodomain near the centre. Table 1
recapitulates the results obtained in this study with the differ-
ent truncated and swapped forms of CDX1 and CDX2. It
comes out from the truncated mutants that the homeodomain
of CDX1 is essential for the interaction with TBP, in addition
to its DNA-binding activity. The homeodomain of other
homeoproteins has also been involved in protein–protein
interactions beside their DNA-binding function (29,30).
Despite its TBP-binding activity, the homeodomain of
CDX1 is not active on the G6Pase promoter unless it is linked
to the N-terminal domain, indicating that this latter domain is
crucial for transcriptional activity, as already reported for the
N-terminal domain of the CDX2 protein (31). Strikingly,
when the CDX2 homeodomain is placed in the context of
the CDX1 N-terminal and C-terminal domains, it becomes
competent for TBP interaction. Moreover, the CDX2
N-terminal domain becomes transcriptionaly active when
associated to the CDX1 homeodomain and C-terminal
domain. This suggests that the N-terminal domains and
homeodomains of both CDX1 and CDX2 have, respectively,
the intrinsic ability to activate transcription and to interact
with TBP and therefore, that the opposite effects of CDX1
and CDX2 on the G6Pase promoter depend on their carboxy
domains. This conclusion is further supported by additional
swapping mutants. Indeed, transcriptional activity (but not
TBP interaction) is lost by changing the C-terminal domain
Table 1. Functional organization of the CDX1 and CDX2 homeoproteins














The organization of the N-terminal domain (ND), the homeodomain (HD) and
the C-terminal domain (CD) of CDX homeoproteins is schematized. (1) and
(2), respectively, designate the CDX1 or CDX2 origin of each domain. Thus,
the wild-type CDX1 and CDX2 proteins appear here as ND1-HD1-CD1 and
ND2-HD2-CD2, respectively. Interaction with TBP is definedby means of co-
immunoprecipitation or GST-pulldown experiments.
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built from the CDX1 N-terminal domain and CDX2 home-
odomain. Moreover, transcriptional activity and TBP interac-
tion is lost by changing the C-terminal domain of CDX1 into
the carboxy domain of CDX2 in the protein built from the
CDX2 N-terminal domain and CDX1 homeodomain. Hence,
in the context of the G6Pase promoter, the CDX2 C-terminal
domain has an inhibitory effect on both CDX1 and CDX2
N-terminal domains responsible for transcription activation,
and it also blunts the TBP interaction activity of the CDX1
homeodomain. Alternatively these data may suggest that
the CDX1 carboxy domain has a stimulatory effect on the
transcriptional and TBP interaction activities of the associ-
ated N-terminal domain and homeodomains. Taken together,
these data uncover the role of the C-terminal domains of
CDX1 and CDX2 as regulators of the functional speciﬁcity
of these homologous proteins.
This study identiﬁes the domains involved in transcrip-
tional activity, interaction with TBP and regulation within
the CDX1 and CDX2 homeoproteins. It suggests that the
speciﬁc activity of these transcription factors depends on
intra-molecular interactions between their domains, with
a major role played by the homeodomain for cooperation
with TBP and the C-terminal domains for controlling active
and inactive conformations of the homeoproteins. Changes
between open and closed conformations of HOX and PBX
homeoproteins have already been proposed to explain their
association with either co-activators or co-repressors (32).
The phosphorylation/de-phosphorylation balance is a common
way to induce conformational changes and to modify interac-
tions with protein partners. Recently, we have identiﬁed
a complex phosphorylation site in the carboxy domain of
CDX2, that can regulate the half-life and activity of the
protein (23). We also have indications that CDX1 is subjected
to post-translational modiﬁcations (I. Gross, unpublished
data). Further studies will investigate if post-translational
modiﬁcations can alter the conformation of CDX1 and/or
CDX2 to change their pattern of interaction with the
transcriptional machinery and thereby to modify their
downstream genetic program during embryonic development,
intestinal homeostasis and/or colorectal cancers.
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